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ABSTRACT 
 The synthesis of bicyclo[2.2.2]diazaoctane prenylated indole alkaloids, containing 
both syn and anti ring fusion, is described. More than 100 examples of alkaloids in this 
family have been isolated and show a variety of potent bioactivities. This strategy utilizes 
the convergent and atom–economic intermolecular hetero Diels–Alder cycloaddition to 
construct the bicyclic nucleus from electron–deficient dienophiles and an electron–rich 
pyrazinone diene. The regiochemical and stereochemical implications of this cyclization 
are investigated. 
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Chapter One 
Bicyclo[2.2.2]diazaoctane Prenylated Alkaloids 
Introduction 
Birch and Wright isolate the brevianamides in 1969, finding for the first time 
natural products which contain the bicyclo[2.2.2]diazaoctane core (Figure 1.1).1 Since 
then, nearly 100 more alkaloids have been isolated which contain this same molecular 
scaffold. Some of these natural products, as well unnatural, synthetic cousins, have shown 
moderate to high biological activity. Because of the variety and intensity of this activity, 
as well as the intrinsic complexity of the molecular structures, the biosynthetic origin of 
the [2.2.2]diazabicycle, as well as methods to synthetically produce the core nucleus, have 
received significant attention. This chapter will summarize the structural diversity, 
proposed biosynthesis, and biological activity of a selected subset of these alkaloids. 
Synthetic strategies towards the bicyclic core will be evaluated in Chapter 2. 
 
 
 
 
 
Figure 1.1 Bicyclo[2.2.2]diazaoctane core 
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Structural Diversity 
  The bicyclo[2.2.2]diazaoctane ring system characterizes this class of molecules 
(selected examples are shown in Figure 1.2), structural features differ among them and 
will be highlighted here.  
   
Figure 1.2 Selected Bicyclo[2.2.2]diazaoctane Alkaloids 
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 Although all members of this family are derived at least partially from a tryptophan 
residue, indole oxidation and prenylation varies greatly. The most prevalent substitution is 
a 2,2–dimethyl–2H–chromene, or benzopyran (highlighted in blue). The dioxepin 
oxidation, highlighted in red, is also observed in a number of diazaoctane alkaloids. Far 
less common is the 2,2–dimethylchroman–4–one moiety (highlighted in green), present 
only in the peniciherquamides. The malbrancheamides uniquely attest to indole 
halogenation. An uncyclized prenyl substitution, highlighted in pink, is present in 
chyrsogenamide A and some notoamides. 
 Three possibilities exist for the ring juncture of the tryptophan onto the bicyclic 
nucleus. First, a 6–membered ring can be attached directly to the indole ring. Secondly, a 
5–membered spirocyclic junction onto a 2–oxindole can be seen following a purported 
biogenic oxidation–rearrangement sequence. The brevianamides uniquely contain a C3 
keto indoline oxidation with a spirocyclic fusion. The diastereoselection of the spirocyclic 
junction likely depends on the C19 diastereochemistry. 
 Figure 1.3 shows representative diagrams for the syn and anti diastereomers of the 
bicyclic core. Examples exist of both diastereomers although the syn isomer predominates.  
 
 
 
 
 
 
Figure 1.3 Diastereomers of the [2.2.2] system 
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 The benzylic locus, which is also the β carbon of the tertiary lactam in 
diketopiperazine derived bicycles, exhibits a variety of oxidation states. Many alkaloids 
are found in the lowest, methylene oxidation state but some have been found at the alcohol 
(e.g., sclerotiamide), vinyl (e.g., avrainvillamide), and ketone (e.g., notoamide I) oxidation 
states (Figure 1.2).  
 The bicyclic nucleus, while broadly conserved across the family, also exhibits a 
variety of oxidation states and substitutions. The presence of a two carbon bridge and two 
nitrogen atoms is common to all bicycles in this family but the six–membered ring which 
forms first in vivo can take two oxidation states: a diketopiperazine or a 
monoketopiperazine. This translates to the presence or absence, respectively, a carbonyl 
adjacent to the tertiary amine. The secondary lactam bridge, found in all known examples 
of this family, has been found with both N–methylation (as in marcfortine A) or as the 
lactim O–methyl ether.  
Finally, these metabolites also show diversity in ring substitution off of the tertiary 
lactam. Figure 1.3 also highlights the proline–derived pyrrolidine ring system. This is by 
far the most common in the family. Marcfortines A and B and chrysogenamide however 
contain the 6–membered pipecolic acid–derived piperidine system. Both the proline and 
pipecolic acid systems can show a range of substitution patterns. 
 
 
 
 
5 
 
The Malbrancheamides 
 The malbrancheamides were first isolated in 2006 from Malbranchea aurantiaca, 
which was cultured from Mexican bat guano, and represents the only class of  
bicyclo[2.2.2]diazaoctane indole alkaloids isolated from a genus other than Penicillium or 
Aspergillus.2, 3 They are also unique in that the malbrancheamides are the only class of 
these alkaloids which exhibit halogenation on the indole system (Figure 1.4). Biologically, 
malbrancheamide and malbrancheamide B are of particular interest due to their calmodulin 
inhibitory activity of CaM–dependent phosphodiesterase (PDE1).4, 6 
 Structural features of the malbrancheamides include a monoketopiperazine ring, 
the aforementioned halogenation, a proline–derived ring, and a syn fusion with the bicyclic 
core. 
 
 
Figure 1.4 The Malbrancheamides 
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 Studies into malbrancheamide biosynthesis by Williams and co–workers have 
yielded the following proposed pathway (Scheme 1.1).5 Condensation of L–tryptophan 
with L–proline and dimethallyl pyrophosphate (DMAPP) affords deoxybrevianamide E 
and subsequent oxidation to a pyrazinone is followed by putative carbonyl reduction and 
subsequent intramolecular Diels–Alder (IMDA). A series of halogenases then install the 
halogen atoms at the necessary sites. Incorporation studies showed that radio–labelled 
keto–premalbrancheamide was not incorporated by M. aurantiaca, suggesting that 
carbonyl reduction occurs before cycloaddition, as indicated below. 
  
 
The Marcfortines and Chrysogenamide A 
 Blue cheese, loved by some and despised by many, was found to contain mold 
cultures of Penicillium roqueforti (now P. paneum) from which marcfortines A–C were 
isolated in 1980 by Polonsky and co–workers.6 Structurally, the marcfortines and the 
closely related chrysogenamide A possess the syn–fused bicyclo[2.2.2] core, a 
monoketopiperazine ring, a spiro–oxindole moiety, and a pipecolic acid ring (Figure 1.5).  
Scheme 1.1 Proposed malbrancheamide biosynthesis 
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           The marcfortines show structural similarity to chrysogenamide A, isolated in 2008 
by Zhu et al. from Penicillium chrysogenum.7 While marcfortines A and B exhibit a 
dioxepin ring and marcfortine C shows the more common pyran moiety, chrysogenamide 
A is the only alkaloid in this family with an isoprene at the C7 indole position. It is also 
one of the only members of the family shown to display neurocyte protection in the face 
of oxidative stress–induced cell death. Chrysogenamide A also possesses the less common 
anti–fused bicyclic core and a substituted pipecolic acid unit, unlike the marcfortines. 
Marcfortine A displays anthelmintic activity, a trait which is also found in the broad class 
of paraherquamides, discussed below. 
 
 
 
 
Figure 1.5 Marcfortines A–C and chrysogenamide A 
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Paraherquamides 
 Consisting of at least 16 related secondary metabolites, the paraherquamide 
subfamily is one of the largest and most structurally diverse of the 
bicyclo[2.2.2]diazaoctane indole alkaloids. Conserved among all members of this 
subfamily is a monoketopiperazine ring, syn fusion like the marcfortines and (excluding 
VM55599 and pre–paraherquamide) a substituted spiro–oxindole moiety (Figure 1.6). 
Many of the paraherquamides exhibit N–methylation on the bridging secondary lactam.  
 
 
  
 
Figure 1.6 Selected paraherquamides and derquantel 
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Paraherquamide A was first isolated from P. paraherquei (also called P. 
brasilianum) in 1981, followed by paraherquamides B–G from P. charlesii. 
Paraherquamides H, I and many related compounds have been isolated from the 
aforementioned soil fungal cultures and others.8  
 Parasitic nematodes pose significant problems to human and animal populations 
and the potent anthelmintic activity of certain paraherquamides have garnered them 
significant interest. Specifically, SB200437 (not shown), SB 203105, and paraherquamide 
A have been shown to act against parasites which have developed resistance to broad–
spectrum anthelmintics.9 However, paraherquamide A also exhibited high toxicity towards 
healthy cells so Pfizer, interested in capitalizing on the potential market profitability, 
synthesized derquantel as a safer alternative.10 Derquantel is now sold as a combination 
treatment with abamectin under the brand name Startect.11 
Peniciherquamides and Mangrovamides 
 Isolated from Penicillium herqui in 2015, peniciherquamides A–C are close 
relatives of the paraherquamides (Figure 1.7).12 Structurally, the peniciherquamides 
exhibit a syn–fused diazabicyclo[2.2.2]octane core, a monoketopiperazine ring with a β–
methylproline moiety, and 2,2–dimethylchroman–4–one functionalized spiro–oxindole 
feature. Peniciherquamide B also uniquely displays O–methylation of the secondary 
lactam.  
10 
 
  
 
 
Other natural products in this family with a β–methylproline ring include 
VM55595, paraherquamide A, and SB203105. The mangrovamides share the unique 2,2–
dimethylchroman–4–one moiety with the peniciherquamides, in addition to the syn–fused 
bicycle but feature N–methylation (except mangrovamide C) and a γ–methylproline.13 
Peniciherquamide C, however, is unique in that it is the only bicyclo[2.2.2]diazaoctane 
prenylated indole alkaloid to show significant anti–hepatitis C virus activity (5.1 μM).12 
The Brevianamides 
 First isolated from Penicillium brevicompactum in 1969 by Birch et al., the 
brevianamides are quintessential members of the [2.2.2]diazabicyclic alkaloid family 
(Figure 1.8).1 The brevianamides show no indole substitution, an unsubstituted proline–
Figure 1.7 Peniciherquamides A–C and selected mangrovamides 
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derived ring, the unusual anti configuration, a unique spiro–indoxyl moiety, and are 
derived from a diketopiperazine, the first of such molecules to be discussed here. Despite 
this relative structural simplicity, brevianamides A and D have shown modest antifeedant 
and insecticidal activity.14 It is important to note that the brevianamides C and D are 
artifacts of isolation to light exposure, not natural products.  
  
  
Birch and co–workers undertook a study of the biosynthetic origins of the 
brevianamides and proposed Scheme 1.2 as a likely route.15 They proposed that the 
condensation of L–tryptophan and L–proline affords brevianamide F. Subsequent reverse 
prenylation would afford deoxy brevianamide E. Multi–step oxidation and cyclization 
would then yield brevianamides A and B.  
Figure 1.8 The Brevianamides A–F 
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 Continued studies by Williams et al. have updated Birch’s original proposal and 
the results of this inquiry is summarized in Scheme 1.3.16 It was observed that radiolabeled 
deoxybrevianamide E was incorporated as brevianamides A, B, and E, thereby supporting 
Birch’s proposal that it was a precursor to cyclization. However, a racemic mixture of a 
brevianamide B–type structure 3 which lacked the spiro–oxindole moiety was not 
incorporated by Penicillium brevicompactum into brevianamide B. This suggests that 
0indole oxidation occurs prior to cyclization. It was thus proposed that deoxybrevianamide 
is selectively oxidized to 1 and then further converted to azadiene 2 which participates in 
an intramolecular Diels–Alder cycloaddition. Synthetic challenges have hindered attempts 
to conclusively validate this pathway. 
Scheme 1.2 Birch’s proposed brevianamide biosynthesis 
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The Stephacidins and Notoamides 
 The final class of bicyclo[2.2.2]diazaoctane–containing prenylated indole alkaloids 
to be discussed here are the broad category containing the stephacidins, notoamides, and 
versicolamides (Figure 1.9). Sclerotiamide was the first to be isolated in 1996 from A. 
sclerotiorum,17a with the stephacidins A and B later isolated from the terrestrial species A. 
ocraceus WC7646617b and avrainvillamide from the marine species Aspergillus sp. 
CNC358.17c,d Notoamides A–R, isolated from a variety of both marine and terrestrial fungi, 
have been key in the continued research into understanding the biosynthesis of this class 
of molecules. 17e–k Stephacidin A, notoamide B, and versicolamide B have also been 
isolated from the terrestrial fungus A. amoenus (formerly A. versicolor)17j and from the 
marine–derived A. protuberus (formerly Aspergillus sp. MF297–2).17h Closer analysis of 
these isolates revealed that the compounds isolated from the two species were in fact 
enantiomers of each other. This represents the first example of enantiomeric reverse 
prenylated indole alkaloids found in nature. 
Scheme 1.3 Williams’s updated brevianamide biosynthesis 
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 This subclass of molecules displays a diketopiperazine core, like the 
brevianamides, and an unsubstituted pyrrolidine ring adjacent to the bicyclic core. The 
versicolamides and the 6–epi natural products are unique in the class in that they exhibit 
anti ring fusion to the bicyclic diketopiperazine; the other members of the subclass show 
the more common syn junction. The indole systems of these compounds are always 
oxygenated, either as the pyran ring or its uncyclized, reverse prenylated precursor as in 
Figure 1.9 Selected stephacidins, notoamides, and versicolamides 
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notoamide T. Finally, these isolates exhibit two kinds of unions with the indole systems: 
5–membered spirocycles and 6–membered rings.  
The isolation of notoamide S from A. amoenus in 2015 by Williams et al., along 
with an enantiomeric mixture of 6–epi–stephacidin, has proven key in elucidating the 
proposed biosynthetic pathway proposed below (Scheme 1.4).17l As before, condensation 
of tryptophan and proline affords brevianamide F which is converted to 
deoxybrevianamide E. Unique to this subclass, the indole ring is oxidized and reverse 
prenylated to yield first 6–hydroxy–deoxybrevianamide E and then the key precursor 
notoamide S. A two–electron oxidation converts notoamide S into a putative achiral 
azadiene which then undergoes intramolecular Diels–Alder cycloaddition to yield one or 
the other enantiomer of notoamide T, depending on the species of fungi in question. 
Cyclization leads to stephacidin A which can then undergo oxidation and a pinacol 
rearrangement to yield one or the other enantiomer of notoamide A, or versicolamide B if 
6–epi–notoamide T was formed.   
Alternatively, (+)–stephacidin A can be oxidized to form (+)–avrainvillamide 
which then dimerizes to form the massive (-)–stephacidin B (Scheme 1.5). Because all 
three of these structures have been isolated, it is clear that this dimerization must occur in 
vivo however the exact mechanism for this is still unclear. Qian–Cutrone and co–workers 
originally proposed that protonation of one monomer to the N–hydroxyindole would lead 
to electrophilic attack of the olefin of another monomer’s center carbocyclic ring.17b This 
would form a secondary carbocation which would then be attacked by the first monomer’s 
secondary lactam bridge to install the five–membered ring, yielding stephacidin B. 
However, Nussbaum has proposed an alternate strategy whereby one monomer’s 
16 
 
secondary lactam nitrogen acts as an aza–Michael addition donor which creates a transient 
N–hydroxyindole on the second monomer.18 This second monomer then acts as a second 
aza–Michael addition donor on the first monomer which then forms the final N–
hydroxyindole system. This is an entirely new system for aza–Michael addition but is 
corroborated by the evidence from the Myers group that simplified derivatives of these 
nitrones undergo Michael addition with methanol at room temperature.19 The Myers group 
found that the dimerization occurs spontaneously when avrainvillamide is exposed to 
triethylamine at room temperature.20 It was later shown that retrodimerization occurs with 
relative ease in vivo, which provides evidence for the hypothesis that avrainvillamide is the 
actual bioactive agent, not stephacidin B.21 
 Scheme 1.5 Synthesis of stephacidin B 
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  Scheme 1.4 Proposed biosynthesis of stephacidins, notoamides, and versicolamides 
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Biological Activity 
 As has been alluded to above, the bicyclo[2.2.2]diazaoctane alkaloids exhibit a 
wide range of bioactivity. Activity ranges from antinematodal to antifeedant, from 
cytotoxic to neuroprotective, and from anti–hepatitis C virus to antibacterial. Table 1.1 
summarizes the available data. 
 
Compound Bioactivity Reference 
malbrancheamide calmodulin inhibitor 2 
chyrsogenamide A neuroprotective agent 7 
marcfortine A anthelmintic 6 
SB203105 anthelmintic 8 
paraherquamide A – G antinematodal 8e 
peniciherquamides C anti–hepatitis C virus 12 
brevianamide A antifeedant 15 
brevianamide D insecticidal  15 
brevianamide F antibacterial 15 
stephacidin A, B cytotoxic 17 
avrainvillamide cytotoxic, antibacterial 17 
  
 The stephacidins and avrainvillamide have been subject to the greatest level of 
scientific scrutiny because of their extremely potent cytotoxicity (~100 μM)21 and novel 
mechanism. After Qian–Cutrone and co–workers17b, Fenical and co–workers17c, and Sugie 
and co–workers17d isolated these three compounds, bioactivity surveys showed their 
cytoxicity against various cancer cell lines, notably the testosterone–sensitive prostate 
cancer type LNCaP. Synthetic efforts by the Myers group to arrive at a simplified 
derivative of avrainvillamide and stephacidin B that only contain the 3–alkylidene–3H–
indole 1–oxide function have shown that this moiety acts a novel Michael acceptor for 
Table 1.1 Bioactivity of selected [2.2.2]-diazaoctane alkaloids 
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nucleophilic alcohols and thiols.19 This simplified, potentially bioactive structure was 
tested alongside avrainvillamide in screens of multiple cancer cell lines and using activity–
based probes, it was determined that avrainvillamide binds to multiple proteins in cancer 
cell lysates which contain nucleophilic cysteine residues.21 Significantly, one such protein 
was found to be nucleophosmin, a multifunctional protein often used for nuclear transport 
in conjunction with exportin–1. Overexpression and cytoplasmic localization of mutant 
nucleophosmin is often seen in patients with acute myeloid leukemia, along with repression 
of p53 which normally either induces DNA repair or apoptosis of cells containing a large 
number of carcinogenic mutations. Studies by Myers et al. have shown that avrainvillamide 
binds to cytosolic nucleophosmin, both wild–type and aberrant form, facilitating its 
nucleolar relocalization which leads to reduction of cancer–like traits of the cell.22 This is 
the first reported case of a small non–petidic molecule acting as an S–alkylating agent on 
the C–terminus of nucleophosmin, leading to the restoration normal cellular function.  
  
20 
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Chapter Two 
Previous Synthetic Strategies 
Introduction 
 Selected synthetic methodologies for constructing [2.2.2]diazabicycles are 
discussed below.  Six distinct strategies have been established in the literature and 
examples representative of each are presented. 
Aminoacyl Radical Strategy 
A synthesis of the oxidized natural product avrainvillamide was undertaken by the 
Myer’s lab soon after its isolation.12 An aminoacyl radical was used to construct the 
[2.2.2]bicyclic manifold found in these alkaloids.  
Synthesis began with unsaturated cyclohexanone 1, made enantioselectively from 
commercially available starting materials in 4 steps (Scheme 2.1). Alkylation with novel 
electrophile 2 proceeded with complete diastereoselectivity to produce 3. Strecker–like 
addition of HCN across the N–Boc enamine moiety proceeded cleanly to give 4. 
Epimerization to the necessary isomer was followed by chemoselective reduction of the 
nitrile to primary amide 5. Exposure to thiophenol and triethylamine induced conjugate 
addition and led to the formation of hemiaminal 6. Following Boc deprotection and 
hemiaminal dehydration, radical initiator 7 was appended to the pyrrolidine ring to afford 
8. Now that the appropriate radical initiator and terminator had been included on the carbon 
skeleton, the envisioned intramolecular radical cyclization could be attempted. To that end, 
t–amyl peroxybenzoate induced hemolytic bond cleavage which led to attack by the 
resultant acyl radical to the enamine carbon in a 6–exo fashion (see highlighted bond) and 
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produced bicycle 9 as a single diastereomer. A 3 step conversion to α–iodoenone 10 was 
followed by Ullmann coupling with aryl halide 11. The resultant nitroarene 12 was reduced 
by zinc powder to afford avrainvillamide as a single enantiomer in 17 steps. Exposure to 
NEt3 in acetonitrile at room temperature resulted in dimerization to stephacidin B. 
  
 
 
 
 
 Scheme 2.1 Myer’s synthesis of avrainvillamide 
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SN2’ Ring Closure 
 The Williams group developed the first ever total synthesis of any diazabicyclic 
indole alkaloid by utilizing an intramolecular SN2’ cyclization to establish the 
[2.2.2]diazaoctane core.2 The [2.2.2] core is established by enolization of a 
diketopiperazine followed by intramolecular nucleophilic attack of a pendant allylic 
chloride (Scheme 2.2). This strategy was successfully employed for synthesis of 
brevianamide B2 and later extended to paraherquamide B3 and stephacidin A4. 
  
The synthesis of stephacidin A began with the substituted tryptophan 13 (Scheme 
2.3).4 Coupling with allyl proline methyl ester 14 yielded dipeptide 15 which was subjected 
to microwave heating to effect ring closure to diketopiperazines 16a,b. A 1:1 mixture of 
syn and anti isomers were observed and separated. Subsequently, the lactim O–methyl 
ether protecting group was introduced on the secondary lactam and the pendant allyl chain 
was subjected to Grubbs cross–metathesis. Allyl chloride 17 was prepared in two further 
steps in anticipation of the SN2’ closure.  As was observed in the synthesis of 
paraherquamide B, SN2’ cyclization of lactim ether protected diketopiperazines results in 
exclusive selectivity for the syn isomer 18.3 In contrast, the Williams synthesis of 
Scheme 2.2 Intramolecular SN2’ ring closure 
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brevianamide B intercepts an unprotected diketopiperazine intermediate which can 
produce either  diastereomer in varying ratios depending on reaction conditions.4 
  
 
 Functional group conversion and closure to the heptacyclic skeleton of stephacidin 
A was completed with special attention to the acid–sensitive nature of the pyran moiety. 
This afforded stephacidin A in 17 steps and 6% overall yield with complete selectivity for 
the syn diastereomer. 
 
Scheme 2.3 Synthesis of stephacidin A via SN2’ cyclization 
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Oxidative Enolate Heterocoupling 
Baran and co–workers devised a route to stephacidin which utilized an 
intramolecular oxidative heterocoupling between ester and amide enolates to construct the 
bicyclic core of these indole alkaloids.5, 6 This work is based on a series of investigations 
in the Baran group on the propensity of carbonyl enolates to react with heterocyclic 
aromatic systems under exposure to metal oxidants such as Cu(II).7 
Carboxybenzyl–protected tryptophan derivative 20 was prepared in 7 steps from a 
reduced pyroglutamate and a protected iodoaniline (Scheme 2.4). This was coupled with 
proline diester 19 (from R–proline in 5 steps) to afford dipeptide 21. Chemoselective 
deprotection of the carboxybenzylamine was followed by thermal ring closure to a 
diketopiperazine. Treatment with MOMCl yielded the N–methylmethoxy protected 
secondary amine 22. At this point, a screen of various metal oxidants revealed that 
Fe(acac)3 was the most propitious for bond formation in the key intramolecular oxidative 
enolate heterocoupling between ester and amide enolates. Bicycle 23 was recovered as a 
single diastereomer but it is still unclear whether this diastereoselectively is the result of a 
chelated transition state or is due to the innate bias of this scaffold. In either case, 23 was 
MOM deprotected, the exocyclic methyl ester was converted to a tertiary alcohol via 
treatment with methyl Grignard and then to the corresponding prenyl residue after 
treatment with Burgess reagent. Finally, thermolytic Boc cleavage and formal ene 
rearrangement likely generated a spirocyclic intermediate which can undergo a 1,2–shift 
to afford (-)–stephacidin A in 20 steps. This synthetic sample was found to be enantiomeric 
with an isolated standard from Fenical lab, thereby proving the absolute chemistry of the 
natural product for the first time.  
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Cationic Cascade 
The Simpkins group envisioned a cationic cascade based on an appropriately 
substituted tryptophan/proline diketopiperazine to forge the characteristic [2.2.2]bicycle.8 
Prenylated proline 23 was synthesized from Seebach proline acetal in 2 steps (Scheme 
2.5). Coupling with indole pyruvic acid occurred in moderate yield to produce the closed 
diketopiperazine 24. Exposure to the Lewis acid TMSOTf induced carbocation formation 
adjacent to the tertiary lactam. Construction of the bicyclic core was completed by 
electrophilic attack on the prenyl pi system, leading to the formation of a tertiary 
carbocation which participated in precedented cyclization onto the indole system. In sum, 
Scheme 2.4 Oxidative enolate heterocoupling synthesis of stephacidin A 
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this pathway yielded bicycles 25a,b in only 5 steps from commercially available starting 
materials and a 4:1 diastereomeric ratio, favoring the syn C–6 epimer.  
 The minor, anti isomer was used to produce ent–brevianamide B in 4 consequent 
steps. The use of an appropriately substituted indole coupling partner led to the production 
of ent–malbrancheamide B in 10 synthetic steps with an equivalent diastereomeric ratio. 
Unfortunately, attempts to extend this methodology to the stephacidins did result in 
productive cyclization due to acid–mediated degradation of the pyran moiety. This 
shortcoming was overcome by a radical cascade (vide infra). 
  
Radical Cascade 
The previous two synthesized outlined above place at their core either anionic 
(enolate) or cationic cyclization strategies. Continued work in the Simpkins group has 
moved into single–electron, radical cyclization chemistry to produce indoline 
[2.2.2]bicyclic alkaloids.9 Previous work in the Baran10a,b and Williams10c labs have shown 
the utility of such indoline precursors as stepping stones to the oxidative synthesis of 
various members of the stephacidin family. 
Scheme 2.5 Cationic cyclization to [2.2.2]diazaoctanes 
29 
 
   
Instead of the α–hydroxy diketopiperazine 24 used in the cationic case, α–
sulphenylated diketopiperazines were envisioned as appropriate precursors to stable radical 
formation.  To that end, mixed proline diketopiperazine 26 was synthesized in 13 steps 
from 6–benzyloxy indole in a manner analogous the α–hydroxy intermediate used 
previously (Scheme 2.5). Exposure to reductive Bu3SnH conditions induced sequential 6–
exo and 6–endo cyclization produce indolines 27a,b in approximately 3:1 diastereomeric 
ratio favoring the syn isomer (Scheme 2.6). Although this represents a marked decrease in 
selectivity from the cationic methodology discussed earlier, the benzopyran moiety found 
in the stephacidins is preserved under these acid–free conditions and subsequent DDQ 
dehydrogenation and Boc deprotection yielded (-)–stephacidin A from 27a. Extension of 
this work utilizing the persistent radical effect has enabled to construction of bridged 
diketopiperazines of bridge length greater than 2 and containing heteroatoms.11 
 
 
Scheme 2.6 Radical cyclization towards indoline [2.2.2]diazaoctanes 
30 
 
Intramolecular Diels–Alder Cycloadditions 
 As was shown in Chapter 1, the prevailing understanding of the scientific 
community is that the [2.2.2]diazabicyclic alkaloids are produced by fungi via an 
intramolecular hetero Diels–Alder cycloaddition (vide supra). Efforts to complete 
biomimetic synthesis of these alkaloids using a variety of intramolecular cycloaddition 
conditions have been undertaken by multiple groups and will be discussed below. 
 The Williams lab keyed in on this powerful, two carbon–carbon bond forming 
reaction in their synthesis of brevianamide B.12 Epi–deoxybrevianamide E was protected 
as the lactim O–methyl ether and dehydrogenation with DDQ afforded 29 (Scheme 2.7). 
Subsequent exposure to aqueous KOH led to the formation of azadiene 30 which 
spontaneously cyclized to give 31 and 32 as a 2:1 mixture of syn and anti. Although only 
single isomers are observed in the biosynthesis of these and related alkaloids, laboratory 
conditions were not able to replicate the same extent of diastereofacial selectivity. 4 steps 
were then required to complete the total synthesis of brevianamide B from minor isomer 
32. 
 The observed preference for the syn fused bicycle has allowed this methodology to 
be applied more broadly to those alkaloids which also exhibit this fusion. For example, 
Scheerer lab developed a stereoselective domino reaction sequence which constructs the 
molecular scaffold common to these alkaloids (Scheme 2.8).13 Specifically, a chiral aminal 
auxiliary was incorporated in the pyrrolidine ring which enforces stereofacialselectivity. 
To that end, diketopiperazine 34 was synthesized in 4 steps from L–serine methyl ester and 
exposed to NaOMe to effect enolization. Condensation with indole aldehyde 33 affords 35 
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Scheme 2.7 Biomimetic Diels–Alder towards racemic brevianamide B 
Scheme 2.8 Chiral auxiliary–enforced IMDA synthesis of malbrancheamide 
B 
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(not isolated) which undergoes alkene isomerization to pyrazinone 36. At this point, [4+2] 
cyclization occurred to afford diastereomers 37 and 38 as a 2:1 mixture favoring the syn 
isomer. After lactim ether hydrolysis, the diastereomers were separated and 9 further steps 
led to the formal synthesis of syn fused malbrancheamide B. 
 Finally, the Williams group extended their previous methodology to the total 
synthesis of stephacidin A.14 Gramine derivative 39 was coupled with β–hydroxy L–proline 
40 to afford a dipeptide (Scheme 2.9). Heating in morpholine prompted cyclization to 
diketopiperazine 41. Mitsonobu–type elimination led to the formation of enamine 42 which 
could be isolated but at elevated temperatures was found to directly participate in the Diels–
Alder cycloaddition. (+)–stephacidin A and its C6 epimer were isolated in a 2.4:1 
diastereomeric ratio, a dr which seems to be consistent across several related examples.   
 
 
 
Scheme 2.9 Improved IMDA towards stephacidin A 
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Chapter Three 
Intermolecular Diels–Alder Cyclizations of Pyrazinones 
Introduction and Retrosynthesis 
 Inspired by the efforts of various laboratories to construct the 
bicyclo[2.2.2]diazaoctane core of these alkaloids via an intramolecular Diels–Alder 
cycloaddition1, we turned our attention to the intermolecular case.2 We theorized that this 
bimolecular reaction might improve the somewhat poor diastereoselectivity (~2:1 favoring 
the syn isomer) observed in nearly all biomimetic intramolecular variants with reverse 
prenylated indole. Although the regiochemistry of the cycloaddition was unclear at the 
outset, the intermolecular strategy might offer a concise entry to the diazabicyclic core. 
 The [2.2.2]diazabicycles 1 and 2 contain the carbon framework that is found in all 
natural products of this family. Syn–configured 1 can be reduced to the 
monoketopiperazine premalbrancheamide, which is the biogenic precursor to 
malbrancheamides A and B.3 Anti–configured 2, while not a natural product, has been 
converted in a few short steps to brevianamide B.4 1 and 2 can be viewed as model 
compounds that represent the most simple syn and anti configured structures that contain 
all rings apparent in the natural product family.  
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 Previous work in the Scheerer lab has established that pyrazinone precursors can 
be prepared in a one–pot aldol–condensation/alkene isomerization domino sequence. The 
coupling of a protected diketopiperazine with indole aldehyde would therefore afford 
pyrazinone 3. This is now ideally prepared for an intermolecular Diels–Alder reaction with 
any range of acrylate derived dienophiles to yield bicycle 4. The regiochemical and 
stereochemical outcomes of this cycloaddition, in addition to questions regarding 
reactivity, were unclear at the start of this project. Acrylate dienophiles or their synthetic 
equivalents were prioritized because treatment with an organometallic reagent (e.g., 
MeMgBr) would afford a tertiary alcohol that is capable of engaging in Friedel–Crafts 
cyclization to complete the ring systems of 1 and 2. Spectroscopic comparison of these 
pentacycles to known standards would prove the stereochemistry of the products of our 
synthesis. 
  
Figure 3.1 [2.2.2]diazabicycles with syn and anti fusion 
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Formal Synthesis of Brevianamide B and Premalbrancheamide 
We began our studies with the synthesis of diketopiperazine 6, which is derived 
from L–proline methyl ester in 3 steps (Scheme 3.2). Exposure of 6 to LiHMDS at –78°C 
led to aldol addition to aldehyde 5. Trapping of the intermediate aldol addition product 
with acetic anhydride led to the isolation of β–acetoxy 7 as a mixture of 4 diastereomers. 
An unpurified mixture was treated with the mild nitrogenous base DBU which induced 
elimination of the acetoxy residue and alkene isomerization to afford pyrazinone 8. While 
this azadiene was not amenable to silica gel chromatography and decomposed when 
exposed to air for a few hours, we were able to purify via recrystallization to obtain a 
homogenous material. 
Diels–Alder   cycloaddition was first attempted with ethyl acrylate and the observed 
cycloadducts were afforded as a 3:1:1 mixture. The major isomer 9 was isolated in 48% 
yield and corresponds to the endo transition state. We could improve the 
diastereoselectivity by utilizing Oppolzer’s sultam acrylamide to deliver 10 as a single 
 
Scheme 3.1 Retrosynthesis of [2.2.2]diazabicycles 
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diastereomer. Unfortunately, 9 and 10 exhibited the undesired regiochemistry whereby the 
carboxyl functionality is not positioned proximal to the indole nucleus. The regiochemistry 
apparent in 9 and 10 does not allow for easy synthesis of 1 or 2.  
  
 
 Computational studies into the transition state energies of similar cycloadducts has 
been pursued to provide greater understanding of the intermolecular pyrazinone Diels–
Alder cycloaddition. Figure 3.2 shows the calculated transition state for the addition of 
ethyl acrylate to α–methyl pyrazinone which would produce the cycloadduct with identical 
regio– and stereochemistry as 9. The potential energy surface shown in Figure 3.3 shows 
roughly even spacing of the four reactant geometries. The calculated transition state for the 
isomer corresponding to 9 lies at least 3.6 kJ mol–1 lower in energy than the other transition 
states. Products A2 and A4 have approximately equal transition state energies, which could 
indicate a 1:1 ratio. The transition state calculated for A3 was found nearly 3 kJ mol–1 
higher than the other examples. From this data, we can conclude that the major isomer of 
this cycloaddition corresponds to 9 and that two other products, which correspond to both 
Scheme 3.2 Intermolecular [4+2] cycloadditions with acrylates 
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diastereomers of the regioisomer, would form in an approximately 1:1 ratio. The fourth 
isomer may or may not be formed. This corroborates our experimental observations 
excellently. The other calculated transition states and IRC graphs for all 4 isomers can be 
found in Appendix II.  
 
 
 
 
We found that the desired regiochemistry was obtained when we utilized methyl 2–
nitroacrylate as the dienophile (Scheme 3.3). This substrate was significantly more reactive 
than the other acrylates studied and underwent cycloaddition at ambient temperatures or 
lower. Cooling the reaction solution to –10 °C and warming to room temperature overnight 
afforded cycloadducts 11 and 12 as a 4:1 mixture in 84% overall yield. Unfortunately, these 
isomers were not readily separable by column chromatography, although it was possible to 
isolate an analytic quantity of 11 for spectroscopic purposes. 
 
 
 
Figure 3.2 Exemplary calculated transition state for pyrazinone [4+2] additions 
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 Attempted radical reduction of the secondary nitro group in cycloadduct 11 with 
Bu3SnH and AIBN in refluxing toluene (110 °C) resulted in the isolation of only the 
elimination product 13. Reduction at lower temperatures (70–80 °C) also led to 13 as the 
major product, however a small quantity of syn–isomer 15 (ca. 10% yield) was also 
observed, thereby validating our stereochemistry from the cycloaddition. It is useful to note 
that while this cycloaddition proceeds in good regioselection and the strong preference of 
the nitro group for the endo transition state enforces the formation of only the syn 
diastereomer, a far cry from the ~2:1 dr observed in the intramolecular case.  
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Figure 3.3 Potential Energy Surface for ethyl acrylate cycloaddition 
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Scheme 3.3 [4+2] cycloaddition with nitro acrylate and nitro–group reduction 
Scheme 3.4 Endgame of formal syntheses of brevianamide B and premalbrancheamide 
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Radical reduction was not a tenable route to arrive at saturated methyl ester 
cycloadducts 15 and 16 (see Scheme 3.4). It was therefore most operationally simple to 
treat the 4:1 mixture of 11 and 12 with stoichiometric DBU, inducing nitro group 
elimination to afford α,β–unsaturated methyl esters 13 and 14 as an easily separable 4:1 
mixture. Hydrogenation with palladium on carbon of 13 led to the isolation of saturated 
methyl esters 15 and 16 in a 1:1 ratio.  
 The ready availability of both syn and anti diastereomers allowed us to move 
forward with the formal syntheses of brevianamide B and premalbrancheamide. 15 was 
treated with excess methyl Grignard to afford the tertiary alcohol 17. Acidic cleavage of 
the lactim ether in 17 was preformed prior to Friedel–Crafts annulation. Their Friedel–
Crafts alkylation of 18 was promoted with p–toluenesulfonic acid in refluxing toluene and 
delivered the desired anti fused 2 in 83% yield. The spectral data for 2 was identical to an 
authentic standard provided by Williams. Acidic hydrolysis of the lactim either 
functionality in 16 let us intercept known lactam 19, an intermediate previously prepared 
by Baran et al. in the syntheses of complex alkaloids in this family5  
 Our synthesis of 2 and 19 represent 12–step formal syntheses of brevianamide B 
and pre–malbrancheamide, representative of anti– and syn–fused [2.2.2] diazabicyclic 
alkaloid natural products. We have provided further insight into pyrazinone Diels–Alder 
cycloadditions and shown that 2–nitroacrylate dienophiles can be used to provide the 
desired regiochemistry and produce only the syn fused bicyclic nucleus in six steps from 
proline methyl ester. 
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Future Work and Early Attempts toward Improved Selectivity 
 Obviously, our synthetic methodology leaves much to be desired in the way of 
diastereoselectivity. Although the intermolecular Diels–Alder with 2–nitroacrylate 
produces two regioisomers with excellent diastereoselectivity for each, the elimination of 
the nitro functionality under basic conditions destroys the stereochemical bias imparted by 
this cycloaddition. Initial attempts at radical reduction of the nitro group proceeded in poor 
yield and could not be improved. The following pages will detail our initial work to 
improve our selectivity and ideas about what could be attempted in the future.  
 We hypothesized that the organoiridium Crabtree’s catalyst might act to 
diastereoselectively add hydrogen across α,β–unsaturated methyl ester 13. Alcohols, esters, 
ureas and a variety of other Lewis–basic functionalities have been evaluated as directing 
groups for iridium hydrogenation catalysts.6 However, lactams and lactims have not yet 
been investigated for this reactivity. Our bicycle provides an ideal substrate to test whether 
the iridium complex has a preference to bind a tertiary lactam over and secondary lactim 
to deliver hydrogen across as double bond selectively. Exposure of 13 to hydrogen gas with 
Crabtree’s catalyst at room temperature afforded exclusively the syn isomer 16 but only in 
15% yield (Scheme 3.5). This result is far from ideal, but we believe that further 
investigation with other catalytic systems, such as ruthenium complexes, may reveal more 
desirable reactivity. 
 Scheme 3.5 Attempts with directed hydrogenation 
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 Following the failure of directed hydrogenation to proceed in good yield, we 
attempted a new approach whereby conjugate hydride addition to the same α,β–unsaturated 
methyl ester would produce an enolate might possibly be selectively protonated in order to 
form 15 or 16. We initially explored Stryker’s reagent, a hexameric copper (I) hydride 
source which has been used in conjugate hydride addition to various α,β–unsaturated 
carbonyl compounds.7 We observed that treatment of 13 with stoichiometric reagent in 
deoxygenated toluene at room temperature afforded a 1:3 ratio of 15 and 16, favoring the 
syn isomer, in near quantitative yields (Scheme 3.6). Unfortunately, we were not able to 
replicate this result because the reagent decomposed within a week, despite our careful 
exclusion of oxygen in a Schlenk flask. Other reagents that promote conjugate addition of 
hydride were examined, including N–selectride. In the event, conjugate reduction at –78 
°C followed by cold methanol quench afforded a similar 1:3 ratio of anti:syn isomers, in 
significantly reduced yields (48% overall). The observed selectivity was not consistent in 
our hands and subsequent reduction attempts demonstrated little selectivity (1:1). These 
results indicate some promise for the selective protonation of the derived enolate of 13 and 
that a preference for the syn isomer might be obtained with continued effort.  
 Scheme 3.6 Conjugate hydride additions to 13 
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 We have also evaluated a number of alternative dienophiles for cycloaddition to 
pyrazinone 8. Table 3.1 lists all dienophiles tested at this time for thermal Diels–Alder 
cycloaddition. Ethyl acrylate gives a 3:1:1 ratio and 2–nitroacrylate gives a 4:1 
regioisomeric ratio with only the syn isomer represented. The cycloaddition appears to 
prefer electron–deficient dienophiles although it is sensitive to nonbonding interactions. 
Tertiary alcohol substitution would ideally intercept 18 or its anti isomer and proceed with 
our above synthesis however no cycloaddition was observed, with either a nitro or carboxyl 
electron withdrawing group. It may be useful to investigate the utility of chiral nitroacrylate 
dienophiles which may be able to access either enantiomeric series of natural products. 
Lewis acid–catalyzed or radical–cation initiated8 Diels–Alder cycloadditions with 8 and 
either p–methoxystyrene or p–allylanisole proceeded either with polymerization of 
dienophile or degradation of azadiene starting material. Intermolecular [4+2] 
cycloadditions to diketopiperazine azadienes such as 8 remain a persistent challenge in 
current synthetic methodology. 
 
Conclusion 
 The formal syntheses of brevianamide B and premalbrancheamide have been 
reported. The [2.2.2]diazaoctane core was constructed via an intermolecular Diels–Alder 
cycloaddition to a diketopiperazine pyrazinone. When 2–nitroacrylate was utilized as 
dienophile, the reaction produced only the syn diastereomer, although that selectivity could 
not be maintained in the course of the synthetic procedure. 
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Table 3.2 Scope of [4+2] annulation with pyrazinone 8 
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Experimentals 
 
tert-Butyl 3-(Acetoxy((8aS)-1-methoxy-4-oxo-3,4,6,7,8,8ahexahydropyrrolo[1,2-
a]pyrazin-3-yl)methyl)-1H-indole-1-carboxylate (7). To DKP 6 (2.16 g, 12.9 mmol) in 
THF (71 mL) at −78 °C was added LiHMDS (14.1 mL, 1 M in THF) dropwise and the 
mixture stirred for 30 min at −78 °C. N–Boc–indole carboxaldehyde 5 (3.31 g, 13.5 mmol) 
was added as a solution in THF (10 mL) dropwise over 5 min, and the reaction was stirred 
for an additional 30 min at −78 °C. Ac2O (1.82 mL, 19.3 mmol) and pyridine (1.55 mL, 
19.3 mmol) were each added dropwise over 5 min, and the cold bath was removed. The 
reaction was allowed to warm to rt and stir for 16 h and was then diluted with HCl (20 mL, 
0.1 M) and extracted with EtOAc (3 × 30 mL). The combined organic extracts were washed 
with satd aqueous NaHCO3 (50 mL), saturated NaCl (50 mL), dried (Na2SO4), filtered, and 
concentrated in vacuo to afford the β–acetoxy product as a mixture of four diastereomers. 
The resulting residue was purified by flash column chromatography on silica gel (gradient 
elution: 30% → 100% EtOAc in hexanes). The four diastereomers were collected together 
to afford a pale yellow amorphous solid (5.32 g, 91% yield): mp 58.0−59.1 °C; TLC (80% 
EtOAc in hexanes) Rf 0.25−0.35 (UV/CAM); IR (film) 2980, 2945, 2886, 1732, 1676, 
1657, 1451, 1368, 1338, 1310, 1252, 1219, 1152, 1080, 1017, 947, 853, 839, 764, 747, 
700, 631, 600, 592 cm−1; 1H NMR (400 MHz, CDCl3) 8.13−8.01 (m, 1H), 7.96−7.91 (m, 
1H), 7.74−7.52 (m, 1H), 7.32− 7.18 (m, 2H), 6.89−6.41 (m, 1H), 4.77−4.28 (m, 1H), 
47 
 
4.05−3.94 (m, 1H), 3.79−3.72 (m, 3H), 3.70−3.63 (m, 1H), 3.50−3.31 (m, 1H), 2.31−2.22 
(m, 1H), 2.16−2.01 (m, 3H), 1.93−1.69 (m, 2H), 1.62− 1.29 (m, 1H), 1.66−1.64 (m, 9H); 
13C NMR (100 MHz, CDCl3): δ 170.2, 169.8, 169.4, 165.9, 165.5, 165.2, 165.1, 163.4, 
163.1, 162.5, 162.4, 149.6, 149.7, 149.5, 135.3, 135.1, 129.8, 129.5, 128.9, 128.6, 125.6, 
125.4, 125.0, 124.7, 124.6, 124.4, 124.3, 124.1, 122.7, 122.6, 122.5, 122.3, 121.8, 120.8, 
120.4, 120.0, 118.6, 116.9, 116.8, 116.7, 115.2, 115.1, 114.8, 84.1, 83.6, 83.6, 71.1, 71.0, 
70.4, 66.0, 65.8, 63.7, 63.4, 56.9, 56.8, 56.6, 56.3, 53.8, 53.7, 53.6, 44.6, 44.4, 44.3, 44.2, 
29.6, 29.4, 29.1, 28.7, 28.3, 28.2, 28.1, 22.6, 22.4, 21.9, 21.7, 21.3, 21.2, 21.1; exact mass 
calcd for C24H29N3O6Na [M + Na]
+ 478.1949, found 478.1946.  
 
tert-Butyl 3-((1-Methoxy-4-oxo-4,6,7,8-tetrahydropyrrolo- [1,2-a]pyrazin-3-
yl)methyl)-1H-indole-1-carboxylate (8). A flame–dried flask was charged with β–
acetoxy aldol addition product 7 (1.37 g, 3.00 mmol), wrapped in aluminum foil, flushed 
with N2 gas for 10 min, and dissolved in PhMe (15 mL) and DMF (3 mL). To the reaction 
flask was added DBU (0.89 mL, 6.00 mmol), and the reaction was stirred for 16 h, diluted 
with HCl (20 mL, 0.2 M), and extracted with EtOAc (3 × 30 mL). The combined organic 
extracts were washed with satd aqueous NaHCO3 (50 mL) and saturated NaCl (50 mL), 
dried (Na2SO4), filtered, and concentrated in vacuo to afford pyrazinone 14 as a yellow 
amorphous solid (1.12 g, 94% yield). The resulting product (0.91 g, quant mass recovery, 
ca. 95% pure by 1 H NMR) was recrystallized (hexanes/EtOAc) to afford analytically pure 
5 (0.38 g, 42% yield) as a yellow amorphous solid. Pyrazinone 5 can be stored (in the dark) 
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for several weeks under inert gas at −15 °C without appreciable degradation: TLC (100% 
EtOAc) Rf 0.40 (UV/CAM); IR (film) 2976, 2939, 1730, 1653, 1584, 1579, 1452, 1369, 
1349, 1256, 1157, 1080, 1046, 1016, 855, 750 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.10 
(s, 1H), 7.75 (d, J = 7.3 Hz, 1H), 7.61 (s, 1H), 7.29−7.19 (m, 2H), 4.19 (s, 2H), 4.14 (t, J = 
7.0 Hz, 2H), 3.82 (s, 3H), 3.04 (t, J = 7.4 Hz, 2H), 2.21 (q, J = 7.4 Hz, 2H), 1.65 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 154.0, 149.8, 149.6, 142.5, 135.5, 130.8, 125.4, 124.2, 
124.1, 122.2, 120.0, 116.7, 115.0, 83.3, 54.8, 49.5, 28.4, 28.2, 28.1, 21.6; exact mass calcd 
for C22H25N3O4 [M + Na]
+ 418.1743, found 418.1735.  
 
Ethyl (6R*,8R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3- yl)methyl)-9-
methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a- (azenometheno)indolizine-8-
carboxylate (9). A flame–dried flask was charged with pyrazinone 8 (227 mg, 0.575 
mmol) and fitted with a reflux condenser. The starting material was dissolved in DMF (3.8 
mL, 0.15 M), and the reaction vessel was degassed (evacuated and backfilled with N2 × 5). 
Ethyl acrylate (0.12 mL, 114 mg, 1.14 mmol) was added, and the reaction vessel was heated 
at 60 °C for 24 h, cooled to rt, and concentrated in vacuo to afford a brown oil. Analysis of 
the unpurified reaction mixture reveals a 3:1:1 mixture of diastereomers. Purification by 
flash column chromatography on silica gel (gradient elution: 30% → 100% EtOAc in 
hexanes) afforded product 9 (138 mg, 48% yield) as a colorless oil: TLC (60% EtOAc in 
hexane) Rf 0.30 (CAM); IR (film) 2985, 2945, 2876, 1736, 1683, 1642, 1456, 1416, 1308, 
1260, 1156, 1085, 1016, 852, 768, 745 cm−1; 1H NMR (400 MHz, CDCl3) 8.10 (br s, 1H), 
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7.78 (d, J = 7.5 Hz, 1H), 7.68 (s, 1H), 7.24 (m, 2H), 4.05 (m, 2H), 3.75 (s, 3H), 3.50−3.30 
(m, 2H), 3.44 (d, J = 14.8 Hz, 1H), 3.34 (d, J = 14.8 Hz, 1H), 2.78 (dd, J = 9.8, 5.5 Hz, 
1H), 2.61 (m, 1H), 2.05−1.85 (m, 4H), 1.80 (dd, J = 13.2, 5.5 Hz, 1H), 1.64 (s, 9H), 1.18 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.3, 163.0, 160.8, 149.5, 134.9, 
132.1, 130.3, 129.0, 128.4, 128.2, 125.3, 124.7, 123.0, 118.9, 116.1, 155.5, 115.1, 104.8, 
83.7, 65.6, 60.7, 54.3, 43.8, 35.0, 32.4, 29.0, 28.2, 28.1, 20.2, 14.0; exact mass calcd for 
C27H33N3O6 [M + Na]
+ 518.2261, found 518.2259.  
 
tert-Butyl 3-(((6R,8R,8aS)-8-((7aR)-8,8-Dimethyl-2,2-dioxidohexahydro-3H-3a,6-
methanobenzo[c]isothiazole-1-carbonyl)- 9-methoxy-5-oxo-2,3,7,8-tetrahydro-1 H -
6,8a- (azenometheno)indolizin-6(5H)-yl)methyl)-1H-indole-1-carboxylate (10). To a 
flame–dried flask were added acryloyl (+)–camphorsultam (135 mg, 0.51 mmol) and 
pyrazinone 8 (188 mg, 0.48 mmol). The flask was fitted with a condenser and flushed with 
N2. The reactants were dissolved in DMF (3.2 mL, 0.15 M), and the vessel was evacuated 
and backfilled with N2 (×5) before heating to 60 °C. After being heated for 24 h, the 
reaction mixture was cooled to rt and concentrated in vacuo to afford a brown oil. Analysis 
of the unpurified reaction mixture by 1H NMR reveals a single cycloadduct as well as some 
unreacted sultam dienophile. Purification by flash column chromatography on silica gel 
(gradient elution: 30% → 70% EtOAc in hexanes) afforded cycloadduct 10 (260 mg, 62% 
yield) as a colorless oil: TLC (80% EtOAc in hexane) Rf 0.3 (CAM); [α]D25 = +59 (c 1.0, 
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CH2Cl2); IR (film) 3854, 3744, 3061, 2986, 2882, 2360, 2337, 1730 1683, 1648, 1635, 
1452, 1363, 1351, 1308, 1298, 1268, 1258, 1218, 1164, 1135, 1083, 1015, 987, 768, 735, 
667, 533 cm−1; 1H NMR (400 MHz, CDCl3) 8.1 (s, 1H), 7.77 (d, J = 1.14 Hz, 1H), 7.66 (s, 
1H), 7.23 (m, 2H), 3.77 (s, 3H), 3.75 (m, 1H), 3.52−3.42 (m, 4H), 3.38 (d, J = 13.7 Hz, 
1H), 3.30 (d, J = 14.8 Hz, 1H), 2.47 (dd, J = 11.7, 6.6 Hz, 1H), 2.15−1.81 (m, 10H), 1.68 
(dd, J = 13.3, 5.5 Hz, 1H), 1.66 (s, 9H), 1.30 (m, 2H), 1.15 (s, 3H), 0.96 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 172.2, 170.9, 169.5, 149.8, 135.1, 132.1, 125.5, 123.6, 121.9, 120.4, 
116.5, 114.8, 83.1, 66.3, 66.2, 65.4, 54.5, 53.1, 49.0 48.2, 47.7, 44.6, 43.2, 38.5, 34.9, 32.9, 
28.8, 28.2, 27.2, 26.3, 24.4, 20.9, 19.8; exact mass calcd for C35H44N4O7S [M + Na]
+ 
687.2823, found 687.2813.  
 
Methyl (6S*,7R*,8R*,8aS*)-6-((1-(tert-Butoxycarbonyl)- 1H-indol-3-yl)methyl)-9-
methoxy-8-nitro-5-oxo-2,3,5,6,7,8- hexahydro-1H-6,8a-(azenometheno)indolizine-7-
carboxylate (11) and Methyl (6S*,7S*,8S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H- 
indol-3-yl)methyl)-9-methoxy-7-nitro-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-8-carboxylate (12). A dry flask was charged with pyrazinone 
8 (531 mg, 1.34 mmol) and flushed with N2 gas for 30 min and dissolved in toluene (7 
mL). A separate flask was charged with nitroacrylate (158 mg, 1.21 mmol) and flushed 
with N2 gas for 30 min and dissolved in toluene (2 mL). The reaction flask containing 
pyrazinone 14 was cooled to −10 °C (ice/salt bath). The nitroacrylate solution was 
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dropwise to the reaction vessel over 10 min. The reaction was allowed to stir and slowly 
warm to rt overnight (16 h). The solution was concentrated in vacuo to afford a brown oil, 
which contained the two regioisomeric cycloadducts 11 and 12 in a 4:1 ratio (as judged by 
1H NMR on the unpurified reaction mixture). The resulting residue was purified by flash 
column chromatography on silica gel (gradient elution: 10% → 80% EtOAc in hexanes). 
A small amount of pure 11 (40 mg) was obtained for analytical purposes and the bulk of 
the material was obtained as a yellow oil that was comprised of a 4:1 mixture of 11 and 12 
(593 mg, 84% yield): TLC (80% EtOAc in hexanes) Rf 0.30, 0.35 (CAM/UV). IR (film) 
3052, 2980, 2950, 1733, 1704, 1641, 1608, 1559, 1477, 1452, 1410, 1370, 1309, 1219, 
1197, 1158, 1086, 1016, 979, 937, 897, 857, 811, 768, 747, 703, 656 cm−1; 1H NMR (400 
MHz, CDCl3): δ 8.13 (d, J = 5.9 Hz, 1H), 7.76 (d, J = 1.6, 1H), 7.74 (d, J = 7.8 Hz, 1H), 
7.29 (dt, J = 8.2, 1.2 Hz, 1H) 7.21 (dt, J = 7.8, 0.8 Hz, 1H), 5.05 (d, J = 4.3 Hz, 1H), 3.77 
(s, 3H) 3.76 (s, 3H), 3.62− 3.52 (m, 3H), 3.34 (d, J = 4.3 Hz, 1H), 3.30 (d, J = 15.7 Hz, 
1H), 2.72−2.66 (m, 1H), 2.25−2.00 (m, 3H), 1.68 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 
169.6, 169.1, 168.7, 149.7, 135.1, 132.0, 125.5, 124.0, 121.9, 120.5, 115.3, 114.9, 88.9, 
83.3, 68.6, 65.3, 55.4, 53.1, 51.0, 44.0, 28.2, 27.2, 26.8, 24.3; exact mass calcd for 
C26H30N4O8Na [M + Na]
+ 549.1953, found 549.1956.  
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Methyl (6S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-yl)methyl)- 9-methoxy-5-
oxo-2,3,5,6-tetrahydro-1H-6,8a-(azenometheno)indolizine-7-carboxylate (13) and 
Methyl (6S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3- yl)methyl)-9-methoxy-5-
oxo-2,3,5,6-tetrahydro-1H-6,8a- (azenometheno)indolizine-8-carboxylate (14). A flask 
was charged with cycloadducts 11 and 12 (ratio 4:1, 588 mg, 1.12 mmol), flushed with N2 
gas, and dissolved in PhMe (18 mL). To the reaction vessel was added DBU (277 μL, 1.86 
mmol), and the reaction mixture was stirred for 16 h at rt, diluted with HCl (0.1 M, 10 mL), 
and extracted with EtOAc (3 × 15 mL). The combined organic portions were washed with 
saturated NaHCO3 (20 mL) and saturated NaCl (20 mL), dried (Na2SO4), filtered, and 
concentrated in vacuo to give the α,β–unsaturated methyl ester regioisomers 13 and 14 in 
a 4:1 ratio as judged by 1H NMR on the unpurified reaction mixture. The residue was 
purified by flash column chromatography on silica gel (gradient elution: 20% → 80% 
EtOAc in hexanes) to afford the minor regioisomer 14 as a light yellow oil (62.1 mg, 12% 
yield) and 13 as a pale yellow powder (376 mg, 70% yield). Spectroscopic data reported 
for 14: TLC (40% EtOAc in hexanes) Rf 0.45 (CAM/UV); IR (film) 2890, 2884, 1721, 
1688, 1634, 1607, 1451, 1369, 1339, 1327, 1308, 1267, 1256, 1244, 1157, 1086, 1044, 
1003, 984, 910, 856, 746, 732, 665 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 7.0 
Hz, 1H), 7.83 (d, J = 7.5 Hz, 1H), 7.68 (s, 1H), 7.50 (s, 1H) 7.33−7.29 (m, 1H), 7.27−7.23 
(m, 1H), 3.80 (s, 3H), 3.73 (d, J = 12.1 Hz, 3H), 3.59 (dd, J = 15.3, 1.2 Hz, 2H), 3.49−3.44 
(m, 1H) 3.19−3.12 (m, 1H) 2.87−2.76 (m, 2H) 2.14−2.04 (m, 1H), 1.98−1.87 (m, 1H) 1.66 
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(s, 9H); 13C NMR (100 MHz, CDCl3): δ 175.4, 169.6, 162.8, 152.8, 149.8, 138.2, 135.1, 
131.7, 124.9, 124.1, 122.3, 120.0, 116.1, 115.0, 83.4, 74.0, 69.4, 56.3, 51.8, 43.0, 28.2, 
26.7, 25.6, 25.4; exact mass calcd for C26H29N3O6 [M + Na]
+ 502.1949, found 502.1944. 
Spectroscopic data reported for α,β–unsaturated methyl ester 13: mp 94.0−95.0 °C; TLC 
(40% EtOAc in hexanes) Rf 0.28 (CAM/UV); IR (film) 2980, 2949, 2882, 1722, 1690, 
1640, 1607, 1451, 1370, 1339, 1304, 1256, 1221, 1155, 1080, 1017, 995, 978, 930, 907, 
856, 835, 764, 739, 619 cm−1 ; 1H NMR (400 MHz, CDCl3): δ 8.06 (s, 1H), 7.81 (dd, J = 
7.1, 1.3 Hz, 1H), 7.62 (s, 1H), 7.28–7.20 (m, 2H), 7.13 (s, 1H), 4.07 (dd, J = 15.6, 0.8 Hz, 
1H), 3.79 (s, 3H), 3.64 (dd, J = 15.6, 0.8 Hz, 1H), 3.40 (s, 3H), 3.40−3.35 (m, 1H), 
3.25−3.19 (m, 1H), 2.74 (m, 1H), 2.25−2.18 (m, 1H), 2.10−2.00 (m, 2H), 1.63 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ 174.4, 169.7, 164.6, 150.0, 147.5, 144.4, 135.1, 132.3, 124.5, 
124.0, 122.1, 120.7, 117.6, 114.9, 83.1, 75.7, 67.6, 56.3, 52.1, 42.7, 28.4, 26.8, 25.5, 25.3; 
exact mass calcd for C26H29N3O6 [M + Na]
+ 502.1949, found 502.1944.  
 
Methyl (6S*,7S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol- 3-yl)methyl)-9-
methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a- (azenometheno)indolizine-7-
carboxylate (15) and Methyl (6S*,7R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)- methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a- 
(azenometheno)indolizine-7-carboxylate (16). Unsaturated ester 13 (182 mg, 0.378 
mmol) was dissolved in MeOH (4 mL) at rt, and 10% Pd/C (25 mg) was added. One balloon 
of H2 gas was used to sparge the reaction mixture (10 min); a second balloon was 
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maintained above the reaction mixture during the course of the reaction to provide an 
atmosphere of H2. When TLC indicated consumption of starting material (1 h), the reaction 
mixture was filtered through Celite, and the filter pad was washed with MeOH. After 
removal of the solvent in vacuo, a white powder was obtained that contained an equal 
mixture of diastereomers as judged by 1H NMR on the unpurified reaction mixture. The 
mixture was purified by flash chromatography on silica gel (20% to 100% EtOAc in 
hexanes) to afford 15 (77 mg, 43% yield) and 16 (78 mg, 43% yield), both obtained as a 
colorless amorphous solids. Spectroscopic data for 15: TLC (60% EtOAC in hexanes) Rf 
0.36 (CAM/UV); IR (film) 2980, 2948, 2883, 1732, 1730, 1695, 1687, 1641, 1476, 1457, 
1452, 1416, 1371, 1360, 1308, 1257, 1213, 1185, 1161, 1084, 1016, 913, 857, 768, 745, 
701, 672 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.07 (d, J = 5.8 Hz, 1H), 7.76 (s, 1H), 7.74 
(d, J = 2.0 Hz, 1H), 7.24−7.19 (m, 2H), 3.78 (s, 3H), 3.54 (d, J = 14.8 Hz, 1H), 3.47 (s, 
3H), 3.44−3.31 (m, 2H), 3.22 (d, J = 14.9 Hz, 1H), 3.06 (q, J = 4.7 Hz, 1H), 2.65−2.58 (m, 
1H), 2.09−1.87 (m, 5H), 1.63 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 172.4, 171.0, 169.9, 
149.9, 134.9, 132.3, 125.7, 123.6, 121.9, 120.3, 116.7, 114.8, 82.8, 69.3, 64.1, 54.7, 51.8, 
45.8, 43.4, 37.3, 28.6, 28.2, 27.5, 24.4; exact mass calcd for C26H31N3O6Na [M + Na]
+ 
504.2105, found 504.2102. Spectroscopic data for 16: TLC (60% EtOAC in hexanes) Rf 
0.43, (CAM/UV); IR (film) 2979, 2948, 2881, 1731, 1693, 1690, 1689, 1452, 1437, 1419, 
1370, 1343, 1301, 1258, 1218, 1162, 1120, 1084, 1045, 1013, 990, 856, 767, 747, 666 
cm−1; 1H NMR (400 MHz, CDCl3): δ 8.09 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.68 (s, 1H), 
7.25 (t, J = 6.2 Hz, 1H), 7.19 (t, J = 7.8 Hz, 1H), 3.75 (s, 1H), 3.71 (s, 3H), 3.68 (s, 3H), 
3.29 (d, J = 15.3 Hz, 1H), 2.76 (q, J = 5.1 Hz, 1H), 2.60− 2.54 (m, 1H), 2.08−1.83 (m, 5H), 
1.66 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 172.9, 172.4, 169.8, 149.9, 135.2, 132.3, 
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125.5, 123.8, 121.8, 121.1, 116.5, 114.8, 83.1, 68.9, 63.3, 54.7, 52.1, 45.2, 43.5, 36.3, 28.7, 
28.2, 27.2, 24.6; exact mass calcd for C26H31N3O6Na [M + Na]
+ 504.2105, found 504.2102.  
 
Methyl (6S*,7S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol- 3-yl)methyl)-9-
methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a- (azenometheno)indolizine-7-
carboxylate (15) and Methyl (6S*,7R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)- methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a- 
(azenometheno)indolizine-7-carboxylate (16). Unsaturated methyl ester 13 (20.2 mg, 
0.042 mmol) was added to a flame–dried reaction flask and dissolved in dry toluene (1 
mL). The solution was sparged with Ar gas for 10 minutes. In a separate flame–dried flask, 
(triphenylphosphine)copper hydride hexamer (37.4 mg, 0.21 mmol) was dissolved in dry 
toluene (1 mL) and sparged with Ar gas for 10 minutes. The copper solution was added 
dropwise to the solution of starting material. The mixture was allowed to stir at rt for 1 h 
then diluted with NH4Cl (5 mL), and extracted with EtOAc (3 × 10 mL). The combined 
organic layers were washed with saturated NaCl (40 mL), dried (Na2SO4), filtered, and 
concentrated in vacuo. Analysis of the unpurified reaction mixture by 1H NMR shows a 
3:1 ratio of syn and anti products, as well as some residual PPh3. Purification by flash 
chromatography on silica gel (25% → 100% EtOAc in hexanes) afforded 15 (7.5 mg, 37% 
yield) and 16 (12.1, 60% yield), both as colorless amorphous solids. Vide infra for 
spectroscopic information. 
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tert-Butyl 3-(((6S*,7S*,8aS*)-7-(2-Hydroxypropan-2-yl)-9- methoxy-5-oxo-2,3,7,8-
tetrahydro-1H-6,8a-(azenometheno)- indolizin-6(5H)-yl)methyl)-1H-indole-1-
carboxylate (17). A flame–dried flask was charged with 15 (12.5 mg, 0.026 mmol) and 
flushed with N2 gas for 10 min, dissolved in toluene (0.52 mL), and cooled to 0 °C. To this 
solution was added MeMgBr (74 μL, 0.104 mmol, 1.4 M in THF). The reaction was stirred 
for 1 h at 0 °C, diluted with NH4Cl (10 mL), and extracted with EtOAc (3 × 10 mL). The 
combined organic layers were washed with saturated NaCl (40 mL), dried (Na2SO4), 
filtered, and concentrated in vacuo. The resulting product was purified by flash 
chromatography on silica gel (50% → 100% EtOAc in hexanes) to afford the derived 
lactim tertiary alcohol 17 as a white foam (7.4 mg, 59% yield): TLC (80% EtOAc in 
hexanes) Rf 0.35 (CAM/UV); IR (film) 3406, 2976, 2945, 2880, 1726, 1661, 1451, 1424, 
1368, 1354, 1256, 1207, 1155, 1103, 1080, 1011, 955, 924, 924, 856, 820, 743 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 8.05 (br s, 1H), 7.84−7.82 (m, 1H), 7.69 (s, 1H), 7.24−7.18 
(m, 2H), 3.75 (d, J = 14.8 Hz, 1H), 3.69 (s, 3H), 3.51 (d, J = 14.9 Hz, 1H), 3.47−3.41 (m, 
1H), 3.28−3.22 (m, 1H), 2.50 (dt, J = 12.9, 7.4 Hz, 1H), 2.35 (dd, J = 9.8, 6.2 Hz, 1H), 2.04 
(dd, J = 12.9, 9.8, 1H), 1.97−1.82 (m, 3H), 1.76 (br s, 1H), 1.63 (s, 9H), 1.41 (dd, J = 12.9, 
6.2 Hz, 1H), 1.32 (s, 3H), 1.22 (s, 3H); 13C (100 MHz, CDCl3) δ 171.5, 169.8, 150.0, 134.8, 
132.6, 125.5, 123.3, 121.7, 120.7, 118.8, 114.7, 82.7, 74.2, 71.7, 63.4, 54.1, 51.9, 43.2, 
37.9, 31.2, 28.6, 28.2, 25.9, 24.2; exact mass calcd for C27H35N3O5Na [M + Na]
+ 504.2469, 
found 504.2468.  
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tert-Butyl 3-(((6S,7S,8aS)-7-(2-Hydroxypropan-2-yl)-5,9-dioxotetrahydro-1H-6,8a-
(epiminomethano)indolizin-6(5H)-yl)- methyl)-1H-indole-1-carboxylate (18). A 
reaction flask was charged with lactim tertiary alcohol 17 (15.8 mg, 0.033 mmol) and 
flushed with N2 gas for 10 min, dissolved in CH2Cl2 (3.5 mL), and cooled to 0 °C. To the 
reaction flask was added p–TsOH·H2O (7.3 mg, 0.038 mmol). The reaction was stirred 
and slowly warmed to ambient temperature over 6 h. The reaction mixture was diluted with 
satd aq NaHCO3 (10 mL), and extracted with EtOAc (4 × 10 mL). The combined organic 
layers were washed with saturated NaCl (40 mL), dried (Na2SO4), filtered, and 
concentrated in vacuo. The resulting product (which contained some amino methyl ester) 
was dissolved in toluene (3 mL) and stirred at 110 °C for 18 h. The solution was 
concentrated in vacuo to obtain lactam tertiary alcohol 18 (15.5 mg, 95% yield) which was 
used without further purification: TLC (80% EtOAc in hexanes) Rf 0.32 (CAM/UV); IR 
(film) 3393, 2928, 1688, 1682, 1674, 1451, 1367, 1339, 1310, 1258, 1221, 1153, 1085, 
1022, 961, 934, 856, 802, 745, 694, 665, 592 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.12 (d, 
J = 7.4 Hz, 1H), 7.64 (s, 1H), 7.60 (d, J = 7.1 Hz, 1H), 7.33−7.16 (m, 2H), 5.70 (br s, 1H), 
4.01 (d, J = 15.6 Hz, 1H), 3.64−3.52 (m, 2H), 3.40 (dt, J = 11.8, 6.6 Hz, 1H), 2.65 (dt, J = 
12.9, 7.4 Hz, 1H), 2.36 (s, 1H), 2.31 (dd, J = 10.2, 6.6 Hz, 1H), 2.13 (dd, J = 13.3, 10.2 Hz, 
1H), 1.97 (apparent quint, J = 7.0 Hz, 2H), 1.82−1.74 (m, 2H), 1.66 (s, 9H), 1.45 (s, 3H), 
1.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 172.4, 169.3, 149.6, 135.1, 131.5, 126.8, 
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124.5, 122.9, 118.0, 115.5, 114.6, 83.7, 73.8, 66.8, 65.8, 50.7, 44.2, 36.2, 32.0, 28.2, 24.1, 
23.7, 23.5; exact mass calcd for C26H33N3O5Na [M + Na]
+ 490.2312, found 490.2312.  
 
12,12-Dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H- 5a,13a-
(epiminomethano)indolizino[7,6-b]carbazole-5,14- dione (2). A reaction flask was 
charged with lactam tertiary alcohol 18 (11.5 mg, 0.025 mmol), fitted with a reflux 
condenser, and flushed with N2 gas for 10 min. PhMe (3.7 mL) and p–TsOH·H2O (4.7 mg, 
0.025 mmol) were added, and the reaction vessel was heated to 100 °C for 6 h. After being 
cooled to rt, the reaction was diluted with satd aqueous NaHCO3 (10 mL) and extracted 
with EtOAc (3 × 10 mL). The combined organic layers were washed with saturated NaCl 
(40 mL), dried (Na2SO4), filtered, and concentrated in vacuo to obtain 2 as a white powder 
(7.1 mg, 83% yield). The material thus obtained was >95% pure as judged by 1H NMR and 
further purification was not performed: TLC (100% EtOAc) Rf 0.45 (CAM/UV); IR (film) 
3325, 3310, 3233, 3221, 3210, 2990, 2947, 2901, 1656, 1670, 1451, 1404, 1369, 1339, 
1300, 1258, 1196, 1161, 1092, 1011, 922, 860, 802, 772, 748, 718, 698, 644, 594 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 7.89 (br s, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 7.9 Hz, 
1H), 7.18 (td, J = 7.5, 1.3 Hz, 1H), 7.12 (td, J = 7.5, 1.2 Hz, 1H), 5.88 (br s, 1H), 3.93 (d, 
J = 18 Hz, 1H), 3.54 (t, J = 6.9 Hz, 2H), 2.91 (d, J = 18 Hz, 1H), 2.81 (quint, J = 6.7 Hz, 
1H), 2.34 (dd, J = 9.8, 4.3 Hz, 1H), 2.18−1.99 (m, 4H), 1.89−1.82 (m, 1H), 1.33 (s, 3H), 
1.28 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 172.7, 169.0, 139.6, 136.4, 127.2, 122.1, 
119.7, 118.3, 110.7, 103.6, 67.1, 61.6, 45.7, 44.2, 34.5, 32.6, 29.1, 29.0, 25.3, 24.5, 23.9. 
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exact mass calcd for spray dimer C42H46N6O4Na [M + M + Na]
+ 721.3473, found 721.3476. 
The spectral data for 2 were identical with an authentic sample provided by Williams 
(Colorado State University).  
 
Methyl (6S,7R,8aS)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3- yl)methyl)-5,9-
dioxohexahydro-1H-6,8a-(epiminomethano)- indolizine-7-carboxylate (19). A 
reaction flask was charged with lactim methyl ester 16 (48 mg, 0.099 mmol) and flushed 
with N2 gas for 10 min, dissolved in CH2Cl2 (10 mL), and cooled to 0 °C. To the reaction 
flask was added p–TsOH·H2O (24 mg, 0.13 mmol), and the reaction was stirred for 6 h 
while slowly warming to rt. The reaction mixture was diluted with satd aq NaHCO3 (10 
mL) and extracted with EtOAc (4 × 10 mL). The combined organic layers were washed 
with saturated NaCl (40 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The 
resulting product (which contained some amino methyl ester) was dissolved in toluene (10 
mL) and stirred at 110 °C for 18 h. The solution was concentrated in vacuo to obtain the 
lactam 19 as a white powder (15.7 mg, 88% yield). The material thus obtained was >95% 
pure as judged by 1H NMR, and further purification was not performed: TLC (70% EtOAc 
in hexanes) Rf 0.30 (CAM/UV); IR (film) 3175, 3117, 3082, 3051, 2978, 2936, 2882, 1736, 
1724, 1690, 1450, 1385, 1362, 1312, 1254, 1196, 1153, 1092, 1308, 1018, 964, 934, 922, 
899, 849, 837, 768, 745, 691, 563 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 8.2 Hz, 
1H), 7.71 (s, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.36 (td, J = 7.6, 1.2 Hz, 1H), 7.29 (td, J = 7.6, 
1.2 Hz, 1H), 5.75 (br s, 1H), 3.82 (s, 3H), 3.66−3.53 (m, 3H), 3.30 (dd, J = 9.8, 4.7 Hz, 
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1H), 3.19 (d, J = 15.6 Hz, 1H), 2.73−2.66 (m, 1H), 2.28−2.15 (m, 2H), 2.10− 1.98 (m, 2H), 
1.85−1.79 (m, 1H), 1.69 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.3, 171.6, 166.4, 149.4, 
135.4, 130.8, 126.2, 125.0, 123.3, 118.1, 115.7, 112.4, 84.1, 66.1, 63.4, 52.7, 48.2, 44.3, 
34.8, 28.9, 28.2, 24.3, 24.0. exact mass calcd for C25H29N3O6Na [M + Na]
+ 490.1949, 
found 490.1948. Spectral data agrees with that reported by Baran.5 
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Appendix I 
Supporting Information for Chapter Three 
General Information. All reactions were carried out under an atmosphere of nitrogen in 
flame–dried or oven–dried glassware with magnetic stirring unless otherwise indicated. 
Acetonitrile, THF, toluene, and Et2O were degassed with argon and purified by passage 
through a column of molecular sieves and a bed of activated alumina.1 Dichloromethane 
was distilled from CaH2 prior of use. All reagents were used as received unless otherwise 
noted. Flash column chromatography2 was performed using silica gel (230–400 mesh). 
Analytical thin layer chromatography was performed on 60Å glass plates. Visualization 
was accomplished with UV light, anisaldehyde, ceric ammonium molybdate (CAM), 
potassium permanganate, or ninhydrin, followed by heating. Film (or KBr pellet) infrared 
spectra were recorded using a FTIR spectrophotometer. Optical rotations were determined 
by a digital polarimeter at 25 °C. 1H NMR spectra were recorded on a 400 MHz 
spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 
ppm) or tetramethylsilane (0.00 ppm). Proton–decoupled 13C NMR spectra were recorded 
on a 400 MHz spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 77.0 ppm). All compounds were judged to be homogeneous (>95% purity) by 
1H and 13C NMR spectroscopy unless otherwise noted as mixtures. Mass spectra data 
analysis was obtained through positive electrospray ionization (ICR–MS w/ NaCl). 
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mixture of 4 diastereomers 
100 MHz 
CDCl3 
mixture of 4 diastereomers 
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ppm012345678
400 MHz 
CDCl3 
 
ppm20406080100120140160180
INDEX    FREQUENCY  PPM      HEIGHT
  1      17326.479  172.189       19.3
  2      17249.079  171.420       19.9
  3      17055.211  169.494       17.2
  4      15081.152  149.876        7.1
  5      13592.867  135.085        7.3
  6      13287.691  132.052       10.1
  7      12629.425  125.510       32.5
  8      12452.512  123.752       28.8
  9      12276.336  122.001       39.8
 10      12105.319  120.302       25.7
 11      11719.795  116.471       22.7
 12      11555.413  114.837       37.7
 13       8365.073  83.132        9.4
 14       7779.784  77.315      146.3
 15       7768.727  77.205       19.4
 16       7748.087  77.000      156.6
 17       7716.390  76.685      148.2
 18       6677.023  66.356       38.9
 19       6602.572  65.616       27.3
 20       6153.654  61.155       35.6
 21       5476.223  54.422       39.0
 22       4927.054  48.965       44.9
 23       4363.142  43.361       35.8
 24       3412.969  33.918       31.7
 25       2898.446  28.805       30.0
 26       2838.001  28.204      151.8
 27       2825.469  28.079       45.6
 28       2473.854  24.585       41.3
 29       1409.424  14.007       38.6
100 MHz 
CDCl3 
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ppm0123456789
400 MHz 
CDCl3 
 
ppm20406080100120140160180
INDEX    FREQUENCY  PPM      HEIGHT
  1      17325.004  172.175       16.3
  2      17193.056  170.864       20.9
  3      17058.897  169.530       20.9
  4      15078.940  149.854        8.2
  5      13598.027  135.136        5.5
  6      13291.377  132.089       11.7
  7      12628.688  125.503       36.1
  8      12439.980  123.628       31.1
  9      12272.650  121.965       34.6
 10      12117.113  120.419       31.8
 11      11719.795  116.471       21.1
 12      11549.516  114.778       34.9
 13       8348.856  82.970       12.9
 14       7780.521  77.322       75.0
 15       7768.727  77.205       22.1
 16       7748.087  77.000       78.9
 17       7716.390  76.685       77.0
 18       6671.126  66.297       35.8
 19       6665.966  66.246       38.2
 20       6584.144  65.433       42.2
 21       5482.120  54.481       36.7
 22       5349.435  53.162       33.6
 23       4931.477  49.009       34.3
 24       4854.814  48.247       46.0
 25       4797.317  47.675       34.2
 26       4492.879  44.650       33.5
 27       4350.611  43.236       31.8
 28       3877.367  38.533       33.6
 29       3509.535  34.878       29.3
 30       3308.296  32.878       28.2
 31       2896.235  28.783       28.7
 32       2840.212  28.226      141.0
 33       2739.224  27.222       40.0
 34       2649.293  26.329       29.4
INDEX    FREQUENCY  PPM      HEIGHT
 35       2451.739  24.365       32.3
 36       2105.284  20.922       42.4
 37       1993.976  19.816       42.1
100 MHz 
CDCl3 
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Appendix II 
Computational Data for Pyrazinone [4+2] Cyclizations 
 
 
 
 
Product 
Ereactants 
(kJ mol–1) 
ETS  
(kJ mol–1) 
Eproducts 
(kJ mol–1) 
A1 0.00 32.2 –53.8 
A2 5.14 35.8 –30.7 
A3 7.65 39.7 –20.8 
A4 2.83 36.9 –41.7 
 
 
 
Figure A.1 [2.2.2]diazaoctanes used in computational studies 
Table A.1 Comparison of computational 
data 
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Figure A.2 Calculated transition state for A1 
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Figure A.3 Intrinsic Reaction Coordinate graph for A1 
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Figure A.4 Calculated transition state for A2 
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Figure A.5 Intrinsic Reaction Coordinate graph for A2 
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Figure A.6 Calculated transition state for A3 
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Figure A.7 Intrinsic Reaction Coordinate graph for A3 
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Figure A.8 Calculated transition state for A4 
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Figure A.9 Intrinsic Reaction Coordinate graph for A4 
